Studies on the cellular functions of lipid-modified proteins
Studies on the cellular functions of lipid-modified proteins
批准号:
07557162
负责人:
OHMURA Satoshi
金额:
$5.12万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Many cellular proteins are modified with lipids such as acyl(palmitoyl or myristoly)and/or prenly(farnesly or geranylgeranyl)residues. In this researach project, the biochemical functions of lipid-modified proteins were studied and searaach for microbial inhibitors of their formation wes carried out as a new approach for anticancer or antiviral agents.HIV Gag protein is myrisstoylataed at the N-terminal glycine residue, which plays an important role in virus particlebdding. The myristoylation levels were controlled to investigate the effect on the particle budding by using the specifiv acyl-CoA synthetase inhibitor triacsin previousy discovered by our group. We showed that the inhibition of Gag myristoylation by triacsin follows dose-dependent kinetics but that the particle budding exhibits sudden shutoff kinetics, suggesting that only a relatively small proportion of total Gag molecules need to be myristoylated for efficient budding and indicating that total inhibition of myristoylation will be required for effective anti-HIV therapy.Oncogene product Ras proteins are posttranslationally farnesylated at the cysteine residue near the C-terminus, in which protein farnesyltransferase(PFTase)is involved. PFTase is expected as a novel target of inhibition since the inhibition causes altering membrane localization and blocking activation of Ras proteins. An efficient screening system was conducted by utilizing Saccharomyces cerevisiae, resulting in discovery of two series of new PTFase inhibitors, andrastins produced by Penicillium sp.FO-3929 and kurasoins by Paecilomyces sp.FO-3684. The structure elucidation including stereochemistries, biosynthesis of andrastin and total sylnthesis of kurasoin were studied. Their inhibitory activity against PFTase (IC_<50>) was 10-60muM.It still remains to be investigated whether or not these compounds inhibit PFTase in cells and show in fvivo anticancer activity.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sunazuka T.: "Synthesis and absolute structures of novel protein farnesyltransferase inhibitors,kurasoins A and B." J.Antibiot.50. 453-455 (1997)
Sunazuka T.:“新型蛋白质法呢基转移酶抑制剂 kurasoins A 和 B 的合成和绝对结构。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Jones I.: "The molecular basis of HIV capsid assembly." Rev.Med.Viol. (1998)
Jones I.:“HIV 衣壳组装的分子基础。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuzawa A.et al.: "Prorection against stress-induced cell death by intracellular PAF acetyihydrolaseII" J.Biol.Chem.272. 32315-32320 (1997)
Matsuzawa A.et al.:“通过细胞内 PAF 乙酰水解酶 II 预防应激诱导的细胞死亡”J.Biol.Chem.272。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Uchida R: "Kurasoins A and B,new protein farnesytransferase inhibitorsproduced by Penicillium sp.FO-3684.I.Producing strain,fermentation,isolation and biological activities." J.Antibiot.49. 932-934 (1996)
Uchida R:“Kurasoins A和B,青霉属sp.FO-3684产生的新型蛋白质法尼基转移酶抑制剂。I.生产菌株、发酵、分离和生物活性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Jones I.M.& Morikawa Y.: "The molecular bisis of HIV capsid assembly" Rev.Med.Virol.(印刷中). (1998)
Jones I.M. 和 Morikawa Y.:“HIV 衣壳组装的分子二元”Rev.Med.Virol.(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 33 条
Development of asymmetric-reversible catalyst via redox mediator
-
批准号:19K15566
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.25万
-
财政年份:2019
-
负责人:OHMURA Satoshi
-
依托单位:
海外基金